Synchronously published &presented at #EASCongress2024 #zodasiran significantly reduces high TGs NEJM #MyEAS2024 #SoMeEAS #EASSoMe European Atherosclerosis Society EAS Congress #EASYoungFellows

Open debate at the #EASCongress2024! The arguments of Raul Santos and Michael D. Shapiro were brilliant and straightforward! Ultimately, there is an overlap between high-risk primary prevention for CVD and secondary prevention❗️

Focusing on preventing atherosclerosis, rather than MI, is a more effective approach for patient management. The disease is #ath not heart attack, and CAC is a late finding❗️For this reason, it does not fit the classic definition of primary prevention #EASCongress2024 #MyEAS2024

Raul Santos #EASCongress2024 #Cardiology #Cardiology #CardioEd #MedTwitter John William McEvoy 's conclusions. Note the "moral hazard consideration". There are data on semaglutide for weight loss in the very young, so, when to stop? No long-term safety data!

AstraZeneca's oral PCSK9i AZD0780 with low food interaction reduces LDL-C 38% as monotherapy and 52% on top of rosuvastatin 20mg in early trial. #eascongress2024

Raul Santos #EASCongress2024 #Cardiology #Cardiology #CardioEd #MedTwitter Jeannine van der Lennep on CVD in women. Attention to early menopause, polycistic ovarian syndromr and...pregnancy complications!

😊 Delighted to be part of #EASCongress2024 as a co-chairman alongside Prof. Alessia Pepe from Italy 🇮🇹. 🙌 Thank you, European Atherosclerosis Society, for the invitation and opportunity! Prof Kausik Ray FMedSci

Something great is happening in Lyon right now! #EASCongress2024 #MyEAS2024 #EASSoMe EAS Congress European Atherosclerosis Society

#EASCongress2024 = oral #PCSK9i with LDL decrease by 38% (not yet comparable to available #PCSK9i or #Inclisiran

Risk factors for ASCVD are under-studied, under-recognised, under-diagnosed and under-treated in women. Furthermore, women are under-represented in clinical trials ❗️ These are critical issues, aren't they? #EASCongress2024 Jeanine RvL EAS Congress eastwest.eu Women As One

Don't forget to ask to your credits claim after the survey of #EASCongress2024

#EASCongress2024

What's the contribution of reduced inflammation to semaglutide's cardiovascular benefits? Jorge Plutzky presents SELECT by hsCRP subgroups at #EASCongress2024 (corrected)

#MyEAS2024 #EASCongress2024 EAS Congress European Atherosclerosis Society I wanna to say that I'm very proud to be EAS member ,EAS Young Fellow EAS always Better,Inspire,Network. Every Year ,EAS made update ,Talent ideas, science, social Network 😊Thanks president EAS Prof Kausik Ray FMedSci

✨ We hope you had a wonderful time learning, exchanging ideas and inspiring each other at the #EASCongress2024! See you in-person next time at the #EASCongress2025 in Glasgow 🙌

Remember that you can earn CME credits for your participation at #EASCongress2024. Make sure you get yours. Check out the congress website to learn how ➡️ bit.ly/4e6ki5h

✨ The #EASCongress2024 photo gallery is now live on our website. Explore the best moments and relive the excitement from this year's event. Check it out now ➡️ bit.ly/4cm7tBY

It's time to announce the #MyEAS2024 Photo Contest winner! 🎉 Congratulations to Laura Comi, who won a free registration to the #EASCongress2025 in Glasgow with her amazing post capturing the essence of the #EASCongress2024!

📢 Missed a session at the #EASCongress2024? On-demand lectures are still available via our virtual platform. Catch up on all the insightful presentations and stay updated with the latest discoveries in the atherosclerosis field ⬇️ bit.ly/4dBMlZl

📢 On-demand lectures from the #EASCongress2024 are still available on our virtual platform! 🎥 Whether you missed a session or want to revisit key insights, you can catch up anytime. Explore and stay updated with the latest research ➡️ bit.ly/4dvxbVF